See every side of every news story
Published loading...Updated

World's first jab to stop skin cancer being tested in UK patients

  • A personalized mRNA cancer jab is being tested in British patients for melanoma, with potential to target bladder, lung, and kidney cancer.
  • In a trial, the jab reduced the risk of cancer recurrence in melanoma patients, leading to a final trial launch.
  • The therapy involves DNA sequencing of a tumor sample and artificial intelligence, showing promising results for high-risk melanoma patients.
Insights by Ground AI
Does this summary seem wrong?

20 Articles

All
Left
4
Center
5
Right
3
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 42% of the sources are Center
42% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Independent broke the news in London, United Kingdom on Thursday, April 25, 2024.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.